Table 2.
Clinical and therapeutic outcome data from CL patients treated with the combination of pentoxifylline and Sbv or placebo and Sbv
Characteristics | Sbv + placebo | Sbv + pentoxifylline | P value* |
---|---|---|---|
Cure rate at 60 days (%) | 35/82 (43) | 39/82 (47.5) | 0.70 |
Cure rate at 180 days (%) | 35/82 (43) | 37/82 (45) | 0.64 |
Healing time (days) (M ± SD) | 99.7 ± 66.2 | 98.1 ± 72.7 | 0.87 |
CL = cutaneous leishmaniasis; M = media; Sbv = pentavalent antimony; SD = standard deviation.
Student's t test.